Literature DB >> 27177489

Is there an Ideal Breast Conservation Rate for the Treatment of Breast Cancer?

M P Tan1.   

Abstract

Since the results of randomised controlled trials in the last quarter of the twentieth century were reported, it has been conventionally accepted that breast conservation treatment (BCT) provides equivalent survival to mastectomy for early breast cancer. As expected, there was an initial fall in the use of mastectomy. The first decade of the twenty-first century, however, witnessed a trend of increasing mastectomy rates in some regions. This perplexing circumstance served as an impetus for a relook at survival outcomes with each surgical modality. Recent studies have demonstrated higher survival rates and improved local control associated with BCT. Such findings warrant a re-evaluation of treatment strategies, beginning with whether there is an optimum BCT rate.

Entities:  

Mesh:

Year:  2016        PMID: 27177489     DOI: 10.1245/s10434-016-5267-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  4 in total

Review 1.  Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis.

Authors:  Michael M Jonczyk; Jolie Jean; Roger Graham; Abhishek Chatterjee
Journal:  Breast Cancer Res Treat       Date:  2018-10-25       Impact factor: 4.872

2.  What are the appropriate thresholds for High Quality Performance Indicators for breast surgery in Australia and New Zealand?

Authors:  Shehnarz Salindera; Michelle Ogilvy; Andrew Spillane
Journal:  Breast       Date:  2020-01-30       Impact factor: 4.380

3.  The Influence of Patient Exposure to Breast Reconstruction Approaches and Education on Patient Choices in Breast Cancer Treatment.

Authors:  Marek K Dobke; Brittany Yee; Gina A Mackert; William Y Zhu; Sarah L Blair
Journal:  Ann Plast Surg       Date:  2019-08       Impact factor: 1.539

4.  Prediction of Short and Long Survival after Surgery for Breast Cancer Brain Metastases.

Authors:  Anna Michel; Marvin Darkwah Oppong; Laurèl Rauschenbach; Thiemo Florin Dinger; Lennart Barthel; Daniela Pierscianek; Karsten H Wrede; Jörg Hense; Christoph Pöttgen; Andreas Junker; Teresa Schmidt; Antonella Iannaccone; Rainer Kimmig; Ulrich Sure; Ramazan Jabbarli
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.